Neutrophilic dermatosis caused by azathioprine

SKINmed

Volumn 9, Issue 6, 2011, Pages 386-388

  Valentine, Mark C ^a   Walsh, John S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Dermatopathology Northwest   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AGED; ARTICLE; BIOPSY; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; PATHOLOGY; TREATMENT OUTCOME;

AGED, 80 AND OVER; AZATHIOPRINE; BIOPSY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISONE; SWEET SYNDROME; TREATMENT OUTCOME;

EID: 84856595833     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964;76:349–356.
2. Strutton G, Weedon D, Robertson I. Pustular vasculitis of the hands. J Am Acad Dermatol. 1995;32:192–198.
3. Walling HW, Snipes CJ, Gerami P, Piette WW. The relationship between neutrophilic dermatosis of the dorsal hands and Sweet syndrome. Arch Dermatol. 2006;142:57–63.
4. Wang YS, Tan A. Neutrophilic dermatosis of the dorsal hands: an emerging entity. J Eur Acad Dermatol Venereol. 2008;23: 451–452.
5. Buck T, González LM, Lambert WC, Schwartz RA. Sweet’s syndrome with hematologic disorders: a review and reappraisal. Int J Dermatol. 2008;47:775–782.
6. Kandula S, Burke WS, Goldfarb JN. Clindamycin-induced Sweet syndrome. J Am Acad Dermatol. 2010;62:898–900.
7. Paoluzi OA, Crispino P, Amantea A, et al. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Dig Liver Dis. 2004;36:361–366.
8. Ali M, Duerkson DR. Ulcerative colitis and Sweet’s syndrome: a case report and review of the literature. Can J Gastroenterol. 2008;22:296–298.
9. Treton X, Joly F, Alves A, Panis Y, Bouhnik Y. Azathioprineinduced Sweet’s syndrome in Crohn’s disease. Inflamm Bowel Dis. 2008;14:1757–1758.
10. Yiasemides E, Thom G. Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol. 2009;50:48–51.
11. el-Azhary RA, Brunner K, Gibson L. Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc. 2008;83:1026–1030.
12. Bidinger J, Sky K, Battafarano D, Henning JS. The cutaneous and Systemic manifestations of azathioprine hypersensitivity syndrome. J Am Acad Dermatol. 2011;65:184–191.
13. de Fonclare AL, Khosrotehrani K, Aractingi S, et al. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. Arch Dermatol. 2007;143:744–748.
14. Marinaki AM, Ansari A, Duley J, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics. 2004;14:181–187.